US-based healthcare technology company Koda Health has secured an oversubscribed, undisclosed amount in a Seed+ funding round.
Ecliptic Capital led the financing round, which also saw significant contributions from AARP, Memorial Hermann Health System and the Texas Medical Center (TMC) Venture Fund.
Memorial Hermann has also partnered with Koda Health on a pilot project, which aims to build on the company’s solutions to boost patient care and support health care providers.
Koda Health operates as a business-to-business (B2B) Enterprise software-as-a-solution (SaaS) platform designed to optimise proactive healthcare planning processes and document works.
Koda Health CEO Tatiana Fofanova said: “If we’re looking at speed of market adoption, it’s clear that Koda Health is at the forefront of a crucial transformation in Advance Care Planning.
“In just a few years, we’ve built out a product that now serves well over 700,000 patients nationwide for industry giants like Cigna, Privia and Houston Methodist.
“While we’re well-equipped to meet these clients’ needs, we’re also signing new partnerships with major healthcare providers at an exciting rate.
“This round of funding will help us maintain the quality that our clients expect at new and unprecedented scales.”
Fofanova founded Koda Health in 2020 alongside its chief technology officer Katelin Cherry and Dr Desh Mohan, who is acting as chief medical officer.
The Texas Medical Center’s (TMCi) Biodesign programme brought the company's founding members together by assigning them the task of developing solutions for issues impacting the medical centre.
Koda Health's advance care planning (ACP) solution can be integrated with a separate Cloud-based ACP platform with in-house 1:1 longitudinal ACP support and navigation.
This approach aims to allow healthcare groups to offer scalable, tailored ACP without needing greater organisational lift.
Koda Health plans to enhance its solutions and boost patient care through strategic collaborations and support from healthcare investors.
